Infantile muscular dystrophy in Canadian aboriginals is an αB-crystallinopathy

Marc R Del Bigio1, Albert E Chudley, Harvey B Sarnat

  • 1Department of Pathology, University of Manitoba, Winnipeg, Canada.

Annals of Neurology
|February 22, 2011
PubMed

Insights

A genetic mutation in the CRYAB gene causes fatal infantile hypertonic muscular dystrophy in Canadian aboriginal infants. This severe condition results from homozygosity for a hypomorphic allele, leading to myofibrillar myopathy.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • A rare, recessively inherited fatal infantile hypertonic muscular dystrophy affects Canadian aboriginal infants.
  • Affected infants exhibit progressive muscle stiffness and severe respiratory insufficiency, often leading to death within the first year of life.

Purpose of the Study:

  • To identify the genetic basis of this severe infantile muscular dystrophy.

Main Methods:

  • Histochemical, immunocytochemical, electron microscopy, and molecular genetic analyses were performed on 12 patients.
  • Mutation screening of the CRYAB gene was conducted in DNA samples from 8 patients.

Main Results:

  • Studies suggested myofibrillar myopathy (MFM).
  • Absence of alpha B-crystallin (αBC) expression was noted, with specific antibody staining revealing abnormalities.
  • A homozygous deletion (c.60delC) in the CRYAB gene, leading to a premature stop codon (p.Ser21AlafsX24), was identified in all affected patients.
  • Heterozygous carriers were identified in unaffected parents.

Conclusions:

  • The homozygous c.60delC mutation in the CRYAB gene is the genetic cause of this fatal infantile hypertonic muscular dystrophy in Canadian aboriginals.
  • Unlike typical dominant MFMs, this disease presents with recessive inheritance due to a hypomorphic allele.
  • The severe phenotype in patients is attributed to homozygosity for this markedly hypomorphic allele, while limited expression rescues parental phenotype.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.